A novel vaccination strategy against certain malignant brain tumors could fundamentally improve treatment for patients.
2don MSN
Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target
A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common ...
ScienceAlert on MSN
Experimental Drug Stops 90% of Pancreatic Cancer Cell Spread in Lab Tests
The pancreas is in the upper part of the abdomen. (Sebastian Kaulitzki/Science Photo Library/Getty Images) Pancreatic ductal ...
A gastrointestinal oncologist told Newsweek that the early-stage findings are a “major step forward” in targeting colon ...
A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such as ...
Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers like lung ...
Researchers tested experimental PCAI compounds against pancreatic cancer cells carrying KRAS mutations. One leading compound ...
A new form of CAR T-cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while ...
Researchers tested experimental PCAI compounds against pancreatic cancer cells and found they had powerful anticancer effects. One leading compound blocked more than 90% of cancer cell migration, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results